ValuEngine Downgrades PURE Bioscience (PURE) to Sell

PURE Bioscience (OTCMKTS:PURE) was downgraded by equities research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Thursday.

PURE Bioscience (PURE) traded down $0.02 during midday trading on Thursday, reaching $1.00. 10,494 shares of the company were exchanged, compared to its average volume of 35,711. PURE Bioscience has a twelve month low of $0.75 and a twelve month high of $1.36.

ILLEGAL ACTIVITY NOTICE: “ValuEngine Downgrades PURE Bioscience (PURE) to Sell” was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of international copyright & trademark laws. The original version of this piece of content can be accessed at https://stocknewstimes.com/2017/11/16/valuengine-downgrades-pure-bioscience-pure-to-sell.html.

About PURE Bioscience

PURE Bioscience, Inc is focused on developing and commercializing antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. The Company’s technology platform is based on stabilized ionic silver and its products contain silver dihydrogen citrate (SDC).

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply